EVLA: Endovenous laser ablation for varicose veins

Written in association with: Professor Vassilis Hadjianastassiou
Published: | Updated: 19/09/2023
Edited by: Sarah Sherlock

Varicose veins can be treated in a variety of ways. In this article, Professor Vassilis Hadjianastassiou goes into thorough explanation about what to expect in the modern EVLA procedure and afterwards.

 

evla treatment varicose veins

 

What is EVLA?

EVLA is a modern, non-surgical and evidence-based method of treating varicose veins that is well-tested and tried. Alternative options for treating varicose veins include: no treatment, compression stockings, surgery or injections into the varicose veins (sclerotherapy). Other methods are also available, such as using microwave (radiofrequency) energy, instead of laser, to destroy the vein and sealing the veins with glue.

 

Since 2004, EVLA has come into widespread use in specialist centres and in the past 15 years it has been perfected. It is a quick, minimally invasive alternative to traditional vein stripping. It has a shorter recovery time than open surgery and patients can walk out within a couple of hours. The vein is destroyed by inserting a laser fibre and laser energy heats the inside of the vein (usually 8 watts, which is much less than the power of a light bulb). The procedure is performed through a tiny cut at the knee level, usually only one to two millimetres long. Several local anaesthetic injections in the leg are necessary, which may result in temporary bruising. The body then naturally absorbs the destroyed veins. It avoids scarring and bleeding and can be performed under local anaesthesia if the patient wants to avoid a general anaesthetic. Light sedation is administered by an anaesthetist during the procedure as the local anaesthetic injections may be uncomfortable for a minute until the anaesthetic works. Some patients request to also have the smaller bulging veins in the leg removed through tiny cuts (stab avulsions). These cuts are usually closed with adhesive tape and do not require stitches, as they are really small. The avulsions are performed after the laser part of your treatment has taken place. This part of the procedure is not required by all patients; however, you can discuss it with your surgeon. When both the laser and avulsions take place, it is generally advisable for patients to undergo a gentle general anaesthetic, rather than sedation and local anaesthetic.

 

 

What are the complications?

There are potential complications with any medical procedure. As the endovenous laser procedure is minimally invasive, there have been minimal complications experienced. Serious complications after EVLA are very rare. Sometimes the procedure cannot be completed as planned and has to be postponed for a later date, or has to be converted to an open surgical procedure. This can happen in less than 1 in 100 cases with both EVLA and foam sclerotherapy when it becomes technically impossible to get access to the veins or to position the instruments correctly through the vein.

 

Expect to have a considerable amount of bruising along the thigh with EVLA. This largely disappears by two weeks but can take longer sometimes to fully resolve. Wearing compression stockings (or bandages) for four days and nights initially and then compression stockings for another ten days (during the day only) helps significantly to minimise the bruising and any discomfort. A feeling of tightness along the length of the vein on the inner aspect of the thigh as the vein contracts over the first four weeks is another common side effect that occurs in most patients. In some patients this can be uncomfortable enough to warrant taking some simple anti-inflammatory tablets, like Ibuprofen (e.g. nurofen) which will usually relieve it adequately. Occasionally you can develop some thread veins following EVLA, normally along the course of the vein that has been lasered but can be in other locations on the leg. If this occurs, then you will require microsclerotherapy injections to clear these up in the outpatient clinic. This is a separate cosmetic procedure and it is not necessary to be done.

 

More serious complications are very rare with EVLA but in theory, it would be possible for any of the following to occur:

 

  1. Deep vein thrombosis and pulmonary embolism. This is the development of a clot occurring in the large deep veins inside the leg or lower tummy. If such a clot travels up to the lungs, this is called a pulmonary embolism, which can cause pain in the chest, breathlessness and even death. We advise all our patients to walk at least 45 to 60 minutes every day (4 to 5 kilometres) for the first week after the procedure which from experience seems to afford them excellent protection.
  2. Skin burns. This was reported in the scientific literature in the first cases of using the laser machinery 15 years ago
  3. Nerve damage. It is not surprising that nerves lying close to the veins having treatment may be damaged, leading to patches of numbness or tingling on the skin, but it is usually mild and temporary. Very seldomly does this continue for longer than three months.
  4. Leg swelling
  5. Infection at the injection sites – theoretically possible but have never seen it in our clinic

 

EVLA front

 

 

Before and after images of varicose veins in the front of a patient's legs with EVLA treatment.

 

EVLA back

 

Before and after images of varicose veins in the back of a patient's legs with EVLA treatment.

 

 

What happens after treatment?

Patients can walk immediately after the procedure and may be allowed home within a few hours after the end of treatment. You will be advised to wear compression stockings (and bandages for the first four days) during the day only (remove them at night) for up to two weeks. You should resume normal activity as soon as possible, normally within two to three days. Hot baths and vigorous activity such as gym workouts should be avoided in the first two weeks. Pain and discomfort for most patients are minimal and usually improve within a few days but can last for longer in others. Flying and excessively long journeys should be avoided for the first two to four weeks due to a slightly increased risk of deep vein thrombosis (DVT). Most patients experience some bruising or pain for up to two weeks, or a tightening sensation along the length of the treated vein but this is usually mild. Simple painkillers like paracetamol and anti-inflammatory drugs like Ibuprofen relieve it very well.

 

 

Will patients need further treatment?

If patients are having treatment just to relieve symptoms, then no further treatment beyond the laser of the main vein is usually necessary. Most patients however wish also to improve the appearance of their veins and of these about 80 per cent will require further treatment to achieve that. The main varicosities normally become much less obvious after EVLA but all varicosities rarely disappear completely. Avulsions (phlebectomies) under local anaesthetic or foam sclerotherapy in the outpatient clinic are additional treatments for these smaller varicosities. More often these additional treatments can be undertaken after a delay of six weeks, as this is the amount of time it takes for the effect of EVLA to show. The commonest means of handling residual varicose veins after EVLA is foam sclerotherapy and it is highly effective.

 

 

If you would like to undergo EVLA treatment for your varicose veins, make a consultation with Professor Vassilis Hadjianastassiou via his Top Doctors profile.

By Professor Vassilis Hadjianastassiou
Vascular surgery

Professor Vassilis Hadjianastassiou is a consultant vascular and general surgeon based in London. He has a special interest in managing varicose veins and diagnosing deep vein thrombosis. With regards to arterial disease, he follows developments very closely in carotid artery surgery. He has extensive experience in complex laparoscopic surgery including hernia repairs, cholecystectomies, adrenalectomies, nephrectomies and kidney transplantation.

He works privately in London at London Bridge Hospital, The London Clinic, the Nuffield Highgate Hospital and Healthshare Clinic West London. He works as a substantive NHS consultant surgeon in vascular surgery, general surgery and kidney transplantation at Bart's Health NHS Trust. Professor Hadjianastassiou graduated from the medical school of the globally-esteemed University of Oxford, where he subsequently also completed his doctoral thesis in abdominal aortic aneurysm risk stratification.

He completed his specialist surgical training at the Oxford and London Deaneries and holds dual GMC accreditation in both vascular surgery and general surgery. Professor Hadjianastassiou is an esteemed figure in surgery. He is currently serving as a member of the court of Examiners at the Royal College of Surgeons of England for the award of the MRCS title. He has served for two consecutive terms as a member of the Executive Council and the treasurer of the Division of Transplantation, of the European Board of Surgery (UEMS). He holds the academic title of full Clinical Professor of Surgery for the University of Nicosia in Cyprus.

He has served for many years as an editorial reviewer for peer-reviewed journals and he has published extensively in scientific literature. Professor Hadjianastassiou's impressive career has also seen him work as the clinical lead for pancreas transplantation at Guy's and St Thomas' NHS Foundation Trust where he was appointed consultant surgeon in 2008. Further to his clinical director role for the Republic of Cyprus' government transplant unit, he also served for two years as one of the two appointed experts in vascular surgery on the government’s advisory committee. There, he introduced the first carotid endarterectomy under local anaesthesia, the first pancreatic organ transplant and the first laparoscopic donor nephrectomy.

He pioneered the Cyprus blood group incompatible kidney transplantation and also did the first fenestrated EVAR for complex abdominal aortic aneurysm repair. In the UK he has pioneered the first two Blood Group Incompatible Kidney transplants in the private sector (HCA, London Bridge Hospital).''

View Profile

Overall assessment of their patients


  • Related procedures
  • Cryo-sclerotherapy
    Hyperhidrosis
    Botulinum toxin (Botox™)
    Vascular disease
    Surgery and vascular testing
    Atherosclerosis
    Pathology of the carotid arteries
    Phlebitis
    Acute limb ischaemia
    Thrombosis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.